Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The production of short-chain fatty acids (SCFAs) by microbiota refers to the biochemical process by which gut bacteria metabolize non-digestible dietary fibers and resistant starches into SCFAs, mainly acetate, propionate, and butyrate. These SCFAs serve fundamental roles in maintaining intestinal health, modulating the immune system, supporting colonocyte energy requirements, and facilitating interactions along the gut-brain axis. The predominant SCFA-producing bacterial taxa include *Bifidobacterium*, *Lactobacillus*, *Roseburia*, *Faecalibacterium prausnitzii*, and members of the *Lachnospiraceae* and *Ruminococcaceae* families. Changes in dietary fiber, microbiota composition, and life stage can impact SCFA production, which, in turn, is linked to multiple disease states. Therapeutic approaches to boost SCFA levels include dietary interventions, prebiotics, probiotics, and in some cases, fecal microbiota transplantation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Production of short-chain fatty acids by microbiota.